【ChiCTR1800018888】Weight-Bearing in Ankle Fractures: UK adherence to the NICE Guidance. An Observational Study.
ChiCTR1800018888
结束
/
/
/
2018-10-15
/
/
踝关节骨折
Weight-Bearing in Ankle Fractures: UK adherence to the NICE Guidance. An Observational Study.
Weight-Bearing in Ankle Fractures: UK adherence to the NICE Guidance. An Observational Study.
OX3 8AX
The purpose of this national study was to audit the weight-bearing practice of orthopaedic services in the National Health Service (NHS) against the standards defined by NICE (The National Institute for Health and Care Excellence).
单臂
回顾性研究
nil
N/A
nil
/
995;531
/
2017-07-03
2017-08-30
/
A multicentre prospective two-week sprint audit of all adult ankle fractures was conducted between July 3rd 2017 and July 17th 2017. Fractures were classified using the AO/OTA classification.;
请登录查看Fractures fixed with syndesmosis screws or unstable fractures treated conservatively were excluded.;
请登录查看英国
OX3 8AX
英国的其他临床试验
- 南京孕产妇尿失禁的发病率以及盆底肌锻炼的知信行调查研究
- The Surgical Management of Cutaneous Abscesses: A UK Cross-Sectional Survey
- 一项旨在研究严重热损伤成人和儿童中性粒细胞功能与脓毒症相关性的国际多中心前瞻性研究(SIFTI-2)
- OUTCOMES FOLLOWING EMERGENCY HERNIA SURGERY AT A LARGE TEACHING HOSPITAL: A CASE SERIES OF 198 CONSECUTIVE CASES OVER A 3 YEAR PERIOD
- Weight-Bearing in Ankle Fractures: UK adherence to the NICE Guidance. An Observational Study.
- REVEAL(调脂药物Anacetrapib疗效的随机评价)
Oxford University Hospital NHS Trust的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

